This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2000 Jan 20;342(3):201-2.

doi: 10.1056/NEJM200001203420309.

ACE inhibition in cardiovascular disease

PMID: 10639547
DOI: 10.1056/NEJM200001203420309

Editorial

ACE inhibition in cardiovascular disease

G S Francis. N Engl J Med. 2000.

. 2000 Jan 20;342(3):201-2.

doi: 10.1056/NEJM200001203420309.

Author

PMID: 10639547
DOI: 10.1056/NEJM200001203420309

No abstract available

PubMed Disclaimer

Comment in

Effect of ramipril on cardiovascular events in high-risk patients.
Gavras H. Gavras H. N Engl J Med. 2000 Jul 6;343(1):65-6. N Engl J Med. 2000. PMID: 10896546 No abstract available.

Comment on

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.
Heart Outcomes Prevention Evaluation Study Investigators; Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Heart Outcomes Prevention Evaluation Study Investigators, et al. N Engl J Med. 2000 Jan 20;342(3):145-53. doi: 10.1056/NEJM200001203420301. N Engl J Med. 2000. PMID: 10639539 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
Miscellaneous
- NCI CPTAC Assay Portal